Ads
related to: betmiga overactive bladder treatment at homeurosupport.com has been visited by 10K+ users in the past month
smartholidayshopping.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Mirabegron, sold under the brand name Myrbetriq among others, is a medication used to treat overactive bladder. [5] Its benefits are similar to antimuscarinic medication such as solifenacin or tolterodine. [6] It is taken by mouth. [5] Common side effects include high blood pressure, headaches, and urinary tract infections. [5]
More recently pharmaceutical companies have developed selective β 3-AR agonists targeted at urinary inconsistencies and in 2012 Mirabegron (trade name Myrbetriq and Betmiga) was the first β 3-AR agonist to be approved in the United States and Europe for the treatment of overactive bladder (OAB) syndrome. [1] [2]
Overactive bladder isn’t a disease but rather a syndrome defined by a collection of symptoms, says Jennifer Linehan, MD, a urologist and associate professor of urologic oncology at the John ...
Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder. [1] [5] [6] Vibegron is a selective beta-3 adrenergic receptor agonist. [1] The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection. [5]
For premium support please call: 800-290-4726 more ways to reach us
Overactive bladder affects approximately 11% of the population and more than 40% of people with overactive bladder have incontinence. [5] [6] Conversely, about 40% to 70% of urinary incontinence is due to overactive bladder. [7] Overactive bladder is not life-threatening, [1] but most people with the condition have problems for years. [1]
Ads
related to: betmiga overactive bladder treatment at homeurosupport.com has been visited by 10K+ users in the past month
smartholidayshopping.com has been visited by 100K+ users in the past month